ABL Bio develops dual-antibody therapeutics targeting immuno-oncology diseases and degenerative brain disorders, utilizing a platform that enhances drug delivery across the blood-brain barrier. Their approach addresses the limitations of existing treatments by improving efficacy and safety profiles for patients with hard-to-treat conditions.

AIDIN ROBOTICS provides advanced force/torque and tactile sensors that give robots precise multi‑axis contact perception. Its compact 6‑axis, miniature, and ankle sensors, along with polymer‑based tactile arrays, are integrated into modular robot hands and smart grippers, supporting standard industrial interfaces for rapid deployment in collaborative, humanoid, and specialized automation applications.

Appota provides a SaaS platform that unifies game, video, book and movie publishing across Android, iOS and social channels via a single API and SDK suite. The platform includes an integrated e‑wallet, programmatic advertising, and real‑time analytics dashboards that give developers and brands data‑driven insights and secure in‑app monetization. It targets game publishers, digital creators and brands operating in Southeast Asian markets.

Auris Health offers the MONARCH™ Platform, a robotic‑assisted bronchoscopy system that provides precise, 6‑degree‑of‑freedom control of a flexible bronchoscope for navigating to peripheral lung lesions. Integrated real‑time navigation software fuses CT imaging with positional data to guide biopsies and therapeutic interventions with sub‑centimeter accuracy, improving tissue acquisition rates while monitoring safety parameters.

Azar provides a cloud‑native, WebRTC‑based platform for instant 1:1 video chats on mobile and web, using an AI‑driven recommendation engine to match users based on interaction patterns and optional gender or region filters. The service includes built‑in safety tools such as automatic screen‑blur and one‑tap reporting, as well as real‑time translation, AR visual effects, and premium filters unlocked through in‑app purchases and subscription tiers.

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing antigen-specific immunotherapies that guide T cells to target chronic infectious diseases and autoimmunity. Their therapies aim to induce sustained reductions in viral antigens, improving patient outcomes in conditions such as chronic hepatitis B and human papillomavirus-related lesions.

Bellsoft provides a platform that creates secure, customizable iframe embeds for third‑party content, handling authentication, sandboxing, and responsive rendering. Users can manage access controls, branding, and interaction settings via a dashboard, while the service ensures compliance with security standards and performance across devices.

Bithumb is a cryptocurrency exchange platform based in South Korea that facilitates the trading of various digital assets through a secure and user-friendly interface. It addresses the need for a reliable marketplace for cryptocurrency transactions, providing users with real-time trading data and robust security measures to protect their investments.

The startup develops therapeutic cell technologies for regenerative medicine, specifically targeting musculoskeletal-related diseases through its proprietary cell therapy platform. This approach addresses the unmet medical need for effective treatments in patients suffering from tissue injuries in the musculoskeletal system.

Doosan Robotics manufactures collaborative robots equipped with advanced torque sensors and high payload capacities, enabling precise and safe automation in various industries. Their robots enhance productivity and efficiency by performing complex tasks while ensuring safety in human-robot interactions.

Eloxx Pharmaceuticals develops small molecule RNA-modulating therapies that target premature stop codon mutations, which disrupt protein synthesis in over 1,800 rare and ultra-rare diseases. Their lead candidate, ELX-02, aims to restore full-length protein production in conditions such as cystic fibrosis and cystinosis, addressing the critical lack of functional proteins in affected patients.

Emoov is a UK‑based online estate agency that lets homeowners and landlords list properties for sale or rent on major portals such as Rightmove, Zoopla and OnTheMarket for a fixed fee, eliminating traditional percentage‑based commissions. The platform provides essential services—including AML checks, market appraisals, professional photography, floor‑plans, video walkthroughs and a dedicated consultant—while owners retain full control over viewings and negotiations via an in‑app messaging system. Optional premium upgrades and completion‑management services are available on an à‑la‑carte basis for additional transparency and flexibility.

Enlivex develops Allocetra™, an off‑the‑shelf allogeneic cell therapy that reprograms macrophages to a homeostatic, anti‑inflammatory state, delivering significant pain reduction and functional improvement for patients with age‑related knee osteoarthritis. The therapy is manufactured as a cryopreserved product for rapid intravenous or intra‑articular administration and is supported by Phase II data showing a favorable safety profile in over 250 patients. Enlivex also backs its corporate treasury with a fee‑linked exposure to the Rain prediction‑markets protocol, aligning shareholder value with network activity.

EToro is a social trading platform that enables users to trade a variety of financial instruments, including currencies, commodities, indices, cryptocurrencies, and stocks, through a user-friendly interface. The platform facilitates peer-to-peer trading and investment strategies, allowing users to leverage the insights and performance of other traders to enhance their investment decisions.

Eubiologics designs and deploys engineered microbial consortia that metabolize persistent organic pollutants in soil and groundwater, using genome‑scale modeling and adaptive evolution to achieve high‑rate degradation under site‑specific conditions. The platform integrates in‑situ biosensor strains, GIS‑driven inoculum placement, and cloud‑based analytics to provide real‑time performance monitoring and reduce remediation timelines and costs for contractors, industrial owners, and regulatory agencies.

The startup develops proprietary controlled release drug formulations to enhance medication adherence for patients with chronic diseases such as diabetes and cancer. By improving the pharmacokinetics of these drugs, the company aims to increase therapeutic efficacy and reduce the frequency of dosing.

Genome Co. is a microbiome research and development company that focuses on the discovery and commercialization of novel probiotics and biologics to enhance human health. Their proprietary GNOCLE™ platform enables the identification of microbial strains that can address specific health conditions, thereby improving treatment options in the field of microbiome medicine.

Halodoc is a health-tech platform that utilizes telemedicine to connect patients with healthcare providers, pharmacies, and laboratories through a single application. It addresses the challenge of accessing medical services by enabling users to consult doctors, schedule hospital visits, and purchase medications conveniently from their devices.

The startup offers a money transfer application that enables users to send remittances and exchange currencies without the need for local bank accounts or extensive identification processes. By utilizing a secure network, the application facilitates rapid cross-border transactions at lower fees, enhancing accessibility for customers.

The startup operates an online travel portal that utilizes a low-cost search engine to provide discounted airfare options for customers. By enabling users to purchase tickets at reduced prices and access advance booking promotions, the platform helps travelers minimize their overall travel expenses.

Hisense Bio develops dental therapeutics utilizing Cell Activation Technology to regenerate dental tissues, specifically targeting intractable conditions such as dentin hypersensitivity, dental caries, and periodontal disease. Their approach enhances the activation of odontoblasts and periodontal ligament fibroblasts, providing a novel treatment option for patients suffering from these persistent dental issues.

HyperAccel engineers specialized AI semiconductors, utilizing a novel LPU architecture designed for high-performance and energy-efficient Generative AI workloads. Their product line spans from edge devices to cloud datacenters, offering optimized solutions for LLM inference. The company supports leading AI frameworks through a dedicated software platform, ensuring seamless integration for developers.

Infludeo is a fan membership platform that facilitates the trading of K-pop photocards through its dedicated marketplace, enhancing the collecting experience for global fans. By offering features like NFC-enabled photocards and physical viewing spots for rare items, it addresses the need for secure and engaging interactions between fans and artists.

Innoface develops hybrid rocket technology for small satellite launch vehicles, providing reliable and cost-effective launch services tailored to customer specifications. The company addresses the need for flexible and rapid satellite deployment in the growing space market.